About this trial
The Westlake Longevity Cohort (We-Longevity) is a prospective cohort study among centenarians, nonagenarians and senior citizens living in Zhejiang Province, China. The primary aim of this cohort is to characterize the multi-omics molecular characteristics of healthy longevity and their dynamic trajectories. The second aim is to culture the gut microbiota of these elderly people through culturomics. The third aim of We-Longevity is to investigate the association of dietary and lifestyle with the multi-omics molecular characteristics of healthy longevity, and to facilitate the development of personalized nutritional/lifestyle recommendation for the public.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants live in Zhejiang Province, China.
Participants intend to remain in Zhejiang Province for ≥3 years.
Disqualifiers
Participants with infectious diseases.
Trial population
All the participants should be Chinese residents, regardless of the ethics.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Physical frailty
Physical frailty will be evaluated by using Fried's criteria.
Gut microbiome
Fecal microbiome will be analyzed by 16S/ITS rRNA gene sequencing and metagenome sequencing. Furthermore, fecal microbiota will be cultured, picked and identified.
Secondary outcomes
Cognitive function
Cognitive function will be evaluated by using Mini-Mental State Examination (MMSE).
Metabolomics profiling
Relative abundance of blood and fecal metabolites will be analyzed by LC-MS/MS.
All-cause survival status
Survival status will be ascertained through data collected from nursing home follow-up surveys.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.